Bowen L, Stein PP, Stevenson R, Shulman GI: The Effect of CP68, 722, a Thiazolidinedione Derivative, on Insulin Sensitivity in Lean and Obese Zucker Rats. Metabolism 40:1025-1030, 1991. |
Chang Ay, Wyse BM, Gilchrist BJ, Peterson T, Diani AR: Ciglitazone, a New Hypoglycemic Agent 1: Studies in OB/OB and DB/DB Mice, Diabetic Hamsters, and Normal and Streptozotocin-diabetic Rats. Diabetes 32:830-38, 1983. |
Fujita T, Sugiyama Y, Taketomi S, Sohda T, Kawamatsu Y, Iwatsuka H, Suzuoki Z: Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4—(Methylcyclohexylmethoxy)benzyl}—thiazolidine-2, 4-dione (ADD-3878, U-63, 287, Ciglitazone), a New Antidiabetic Agent. Diabetes 32:804-810, 1983. |
Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H: “Characterization of New Oral Antidiabetic Agent CS-O45 Studies in KK and OB/OB Mice and Zucker Fatty Rats.” Diabetes 37: 1549-58, 1988. |
O'Rourke CM, Davis J, Saltiel AR, and Cornicelli JA: Metabolic Effects of Troglitazone in the Goto-kakizaki rat, a Non-obese and Normolipidemic Rodent Model of Non-insulin-dependent Diabetes Mellitus. Metabolism 46:192-198, 1997. |
Kraigen EW, James DE, Jenkins AB, Chisholm DJ, Storlien LH: “A Potent in Vivo Effect of Ciglitazone on Muscle Insulin Resistance Induced by High Fat Feeding of Rats.” Metabolism 38: 1089-1093, 1989. |
Iwamoto Y, Kuzuya T, Matsuda A, Awata T, Kumakura S, Inooka G, Shiraishi I: “Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDM.” Diabetes Care 14: 1083-86, 1991. |
Kuzuya T, Iwamoto Y, Kosaka K, Yamanoushi T, Kasuga M, Kajinuma H, Akanuma Y, Yoshida S, Shigeta Y, Baba S: “A Pilot Clinical Trial of a New Oral Hypoglycemic Agent, CS-045, in Patients with Non-Insulin Dependent Diabetes Mellitus.” Diabetes Res. And Clin Practice. |
Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM: “Metabolic Effects of New Oral Hypoglycemic Agent CS-O45 in NIDDM Subjects.” Diabetes Care 15:193-203, 1992. |
William GD, Delda A, Jordan WH, Gries C, Long GG, Dimarchi RD: Subchronic Toxicity of the Thiazolidinedione, Tanabe-174 (LY 282449), in the Rat and Dog. Diabetes 42: 1993. |
Hvdberg, A., Nielsen, T.M., Hilsted, J., Orskov, C., and Holst, J. J. “Effect of Glucagon-Like Peptide-1 (proglucagon 78-107 amide) on hepatic glucose production in healthy man.” Metabolism, vol 43, #1 (Jan.), 1994 pp 104-108. |